Physician profile
Tejas B Patel
NPI 1083861017
$423.40
in general payments reported to CMS, 2019-2025
12 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.63 · 2021: $16.00 · 2022: $37.59 · 2023: $119 · 2024: $94.13 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.55 | 2024-2025 | Jardiance, Synjardy, Tradjenta |
| Janssen Scientific Affairs, LLC | $72.18 | 2023 | Tremfya |
| Bayer Healthcare Pharmaceuticals INC. | $53.09 | 2022-2025 | |
| Novo Nordisk INC | $47.05 | 2023-2024 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $33.02 | 2020-2025 | Airsupra |
| Abbott Laboratories | $24.44 | 2025 | Aveir |
| Exact Sciences Corporation | $23.45 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $20.60 | 2024 | Trelegy Ellipta |
| Lilly USA, LLC | $17.83 | 2025 | Zepbound |
| Itamar Medical INC | $17.45 | 2025 | Watchpatone |
| Abbvie INC. | $16.00 | 2021 | |
| Medicure Pharma INC. | $14.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tejas Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.